KRAS and AIDS dementia complex: Furthermore, in the phase I study, patients who were male, or had a history of smoking, or had an ECOG score of 1, or had pathological type of ADC, or had KRAS mutation in exon 2, or had 2 or more lines of standard treatment, or had 3 or more metastases, received a favorable ORR (Supplementary Table 5).